“the actual submission is likely to be early 2024, after the adult trial commences.but if the FDA suggest that an AA submission would be a viable option, then that will bring forward potential approval by a fair bit as the AA review itself is unlikely to take very long with the manufacturing inspection already given the green tick. We will know shortly as @ddwn suggests, but clearly this possibility is not factored into the current share price and presents an opportunity for those who think it could come to fruition.” —> This was @stockrock ‘s reply to @07Gerard on 10 Aug.
If you are interested, I think @stockrock gave some background to the thinking in his reply - you can do an advanced search for his earlier post on the same day.
I wonder if anyone would be asking this process question at the upcoming results CC - seems to me to be highly relevant, @LearningEachDay, @ddwn, @Phaedrus - any thoughts?
- Forums
- ASX - By Stock
- MSB
- 2023 Next Steps
2023 Next Steps, page-86
-
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.01 |
Change
-0.005(0.50%) |
Mkt cap ! $1.147B |
Open | High | Low | Value | Volume |
$1.02 | $1.02 | $1.00 | $587.3K | 581.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 117550 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 47622 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 117550 | 1.000 |
9 | 116349 | 0.995 |
14 | 127506 | 0.990 |
6 | 132488 | 0.985 |
9 | 112979 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 47622 | 15 |
1.010 | 66199 | 15 |
1.015 | 50148 | 9 |
1.020 | 156821 | 12 |
1.025 | 112704 | 6 |
Last trade - 11.26am 19/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |